Maggot Therapy for Foot and Leg Wounds

The International Journal of Lower Extremity Wounds

Volumn 1, Issue 2, 2002, Pages 135-142

  Sherman, Ronald A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

diabetes; maggot therapy; pressure ulcer; skin ulcer; therapy of; venous stasis; wounds

Indexed keywords

EID: 84993705037     PISSN: 15347346     EISSN: None     Source Type: Journal    
DOI: 10.1177/1534734602001002009     Document Type: Article

References (65)

1. Pechter EA, Sherman RA. Maggot therapy: the medical metamorphosis. Plast Reconstr Surg 1983; 72: 567-570.
2. Baer WS. Sacro-iliac joint—Arthritis deformans—Viable antiseptic in chronic osteomyelitis. Proc Int Assembly Interstate Postgrad Med Assoc North Am 1929; 371: 365-372.
3. Baer WS. The treatment of chronic osteomyelitis with the maggot (larva of the blowfly). J Bone Joint Surg 1931; 13: 438-475.
4. Robinson W. Progress of maggot therapy in the United States and Canada in the treatment of suppurative diseases. Am J Surg 1935; 29: 67-71.
5. Puckner WA. New and nonofficial remedies, surgical maggots-Lederle. J Am Med Assoc 1932; 98: 401.
6. Horn KL, Cobb AH, Gates GA. Maggot therapy for subacute mastoiditis. Arch Otolaryngol 1976; 102: 377-379.
7. Teich S, Myers RAM. Maggot therapy for severe skin infections. South Med J 1986; 79: 1153-1155.
8. Valencia IC, Falabella A, Kirsner RS, et al. Chronic venous insufficiency and venous leg ulceration. J Am Acad Dermatol 2001; 44: 401-421.
9. Frykberg RG. Epidemiology of the diabetic foot: ulcerations and amputations. Adv Wound Care 1999; 12: 139-141.
10. National Pressure Ulcer Advisory Panel. Pressure ulcers prevalence, cost, and risk assessment: consensus development conference statement. Decubitus 1989; 2: 24-28.
11. National Pressure Ulcer Advisory Panel. Pressure ulcers in America: prevalence, incidence, and implications for the future. An executive summary of the National Pressure Ulcer Advisory Panel Monograph. Adv Wound Care 2001; 14: 208-215.
12. Allman RM, Goode PS, Burst N, et al. Pressure ulcers, hospital complications, and disease severity: impact on hospital costs and length of stay. Adv Wound Care 1999; 12: 22-30.
13. Burd C, Langemo D, Olson B, et al. Skin problems: epidemiology of pressure ulcers in a skilled care facility. J Gerontol Nurs 1992; 18: 29-39.
14. Sherman RA. Maggot therapy: the last five years. Bull Eur Tissue Repair Soc 2000; 7: 97-98.
15. Sherman RA, Wyle FA, Vulpe M. Maggot debridement therapy for treating pressure ulcers in spinal cord injury patients. J Spinal Cord Med 1995; 18: 71-74.
16. Wayman J, Nirojogi V, Walker A, et al. The cost effectiveness of larval therapy in venous ulcers. J Tissue Viability 2000; 10: 91-96.
17. Mumcuoglu KY, Ingber A, Stessman J, et al. Maggot therapy for the treatment of diabetic foot ulcers. Diabetes Care 1998; 21: 2030-2031.
18. Fleischmann W, Russ M, Moch D, et al. Biosurgery—maggots, are they really the better surgeons?. Chirurg 1999; 70: 1340-1346.
19. Sherman RA, Sherman JMT, Gilead L, et al. Maggot debridement therapy in out-patients. Arch Physical Med Rehab 2001; 82: 1226-1229.
20. Sherman RA, Hall MJR, Thomas S. Medicinal maggots: an ancient remedy for some contemporary afflictions. Annu Rev Entomol 2000; 45: 55-81.
21. Zumpt F. Myiasis in man and animals in the old world. London: Butterworths; 1965.
22. Hall MJR, Wall R. Myiasis of humans and domestic animals. Adv Parasitol 1995; 35: 257-334.
23. Hobson RP. On an enzyme from blowfly larvae (Lucilia sericata) which digests collagen in alkaline solution. Biochemistry 1931; 25: 1458-1463.
24. Hobson RP. Studies on the nutrition of blowfly larvae: I. Structure and function of the alimentary tract. J Exp Biol 1931; 8: 110-123.
25. Maseritz IH. Digestion of bone by larvae of Phormia regina. Arch Surg 1934; 28: 589-607.
26. Waterhouse DF, Irzykiewicz H. An examination of proteolytic enzymes from several insects for collagenase activity. J Insect Physiol 1957; 1: 18-22.
27. Ziffren SE, Heist HE, May SC, et al. The secretion of collagenase by maggots and its implication. Ann Surg 1953; 153: 932-934.
28. Brookes VJ. Partial purification of a proteolytic enzyme from an insect, Phormia regina. Biochim Biophys Acta 1961; 46: 13-21.
29. Fraser A, Ring RA, Stewart RK. Intestinal proteinases in an insect, Calliphora vomitoria L. Nature 1961; 4806: 999-1000.
30. Pendola S, Greenberg B. Substrate-specific analysis of proteolytic enzymes in the larval midgut of Calliphora vicina. Ann Entomol Soc Am 1975; 68: 341-345.
31. Vistnes LM, Lee R, Ksander GA. Proteolytic activity of blowfly larvae secretions in experimental burns. Surgery 1986; 90: 835-841.
32. Casu RE, Pearson RD, Jarmey JM, et al. Excretory/secretory chymotrypsin from Lucilia cuprina: purification, enzymatic specificity and amino acid sequence deduced from mRNA. Insect Mol Biol 1994; 3: 201-211.
33. Livingston SK, Prince LH. The treatment of chronic osteomyelitis with special reference to the use of the maggot active principle. J Am Med Assoc 1932; 98: 1143-1149.
34. Robinson W. The use of blowfly larvae in the treatment of infected wounds. Ann Entomol Soc Am 1933; 26: 270-276.
35. Robinson W, Norwood VH. Destruction of pyogenic bacteria in the alimentary tract of surgical maggots implanted in infected wounds. J Lab Clin Med 1934; 19: 581-586.
36. Greenberg B. Model for destruction of bacteria in the midgut of blowfly maggots. J Med Entomol 1968; 5: 31-38.
37. Mumcuoglu KY, Miller J, Mumcuoglu M, et al. Destruction of bacteria in the digestive tract of the maggot of the green bottle fly, Lucilia Sericata (abstract). Fifth International Conference on Biotherapy Wurzburg, Germany, June 29-30, 2000.
38. Erdmann GR, Khalil SKW. Isolation and identification of two antibacterial agents produced by a strain of Proteus mirabilis isolated from larvae of the screwworm (Cochliomyia hominivorax) (Diptera: Calliphoridae). J Med Entomol 1986; 23: 208-211.
39. Simmons SW. A bactericidal principle in excretions of surgical maggots which destroys important etiological agents of pyogenic infections. J Bacteriol 1935; 30: 253-267.
40. Pavillard ER, Wright EA. An antibiotic from maggots. Nature 1957; 180: 916-917.
41. Keppi E, Zachary D, Robertson M, et al. Induced antibacterial proteins in the haemolymph of Phormia terranovae (DIPTERA); purification and possible origin of one protein. Insect Biochem 1986; 16: 395-402.
42. Friedman E, Shaharabany M, Ravin S, et al. Partially purified antibacterial agent from maggots displays a wide range of antibacterial activity (abstract). Third International Conference on Biotherapy, Jerusalem, Israel, May 24-27, 1998.
43. Mumcuoglu KY, Miller J, Loffe-Uspensky I, et al. The potential of maggots to secrete cytokines in vitro (abstract). Fifth International Conference on Biotherapy Wurzburg, Germany, June 29-30, 2000.
44. Prete PE. Growth effects of Phaenicia sericata larval extracts on fibroblasts: mechanism for wound healing by maggot therapy. Life Sci 1997; 60: 505-510.
45. Wollina U, Fassler D, Schmidt WD, et al. Biosurgery supports granulation and debridement and improves oxygen supply in chronic wounds (abstract). Fifth International Conference on Biotherapy Wurzburg, Germany, June 29-30, 2000.
46. Namias N, Varela JE, Varas RP, et al. Biodebridement: a case report of maggot therapy for limb salvage after fourth-degree burns. J Burn Care Rehab 2000; 21: 254-257.
47. Sherman RA. Maggot therapy in modern medicine. Infect Med 1998; 15: 651-656.
48. Dicke RJ. Maggot treatment of actinomycosis. J Econ Entomol 1953; 46: 706-707.
49. Wolff H, Hansson C. Larval therapy for a leg ulcer with methicillin-resistant Staphylococcus aureus. Acta Derm Venereol 1999; 79: 320-321.
50. Thomas S, Jones M, Shutler S, et al. Using larvae in modern wound management. J Wound Care 1996; 5: 60-69.
51. Evans H. A treatment of last resort. Nursing Times 1997; 93: 62-65.
52. Rayman A, Stansfield G, Woolard T, et al. Use of larvae in the treatment of the diabetic necrotic foot. Diabetic Foot 1998; 1: 7-13.
53. Óvári A, Farkas R, Adrián E. Experiences in wound treatment with sterile maggots in Hungary [in Hungarian]. Lege Artis Medicinae 1998; 8: 874-879.
54. Buchman J, Blair JE. Maggots and their use in the treatment of chronic osteomyelitis. Surg Gynecol Obstet 1932; 55: 177-190.
55. Livingston SK. Maggots in the treatment of chronic osteomyelitis, infected wounds, and compound fractures. An analysis based on the treatment of one hundred cases with a preliminary report on the isolation and use of the active principle. Surg Gynecol Obstet 1932; 54: 702-706.
56. Weil GC, Simon RJ, Sweadner WR. A biological, bacteriological and clinical study of larval or maggot therapy in the treatment of acute and chronic pyogenic infections. Am J Surg 1933; 19: 36-48.
57. Bunkis J, Gherini S, Walton RL. Maggot therapy revisited. West J Med 1985; 142: 554-556.
58. Reames MK, Christensen C, Luce EA. The use of maggots in wound debridement. Ann Plast Surg 1988; 21: 388-391.
59. Seaquist ER, Henry TR, Cheong E, et al. Phormia regina myiasis in a malignant wound. Minn Med 1983; 66: 409-410.
60. Thomas S, Andrews A. The effect of hydrogel dressings on maggot development. J Wound Care 1999; 8: 75-77.
61. Sherman RA, Wyle FA, Thrupp L. Effects of seven antibiotics on the growth and development of Phaenicia sericata (DIPTERA: Calliphoridae) larvae. J Med Entomol 1995; 32: 646-649.
62. Stewart MA. The role of Lucilia sericata Meig. larvae in osteomyelitis wounds. Ann Trop Med Parasitol 1934; 28: 445-460.
63. Grantham-Hill C. Preliminary note on the treatment of infected wounds with the larva of Wohlfahrtia nuba. Trans R Soc Trop Med Hyg 1933; 27: 93-98.
64. Guerrini VH. Ammonia toxicity and alkalosis in sheep infested by Lucilia cuprina larvae. Int J Parasitol 1988; 18: 79-81.
65. Sherman RA. A new dressing design for treating pressure ulcers with maggot therapy. Plast Reconstruct Surg 1997; 100: 451-456.